Abstract:As of 31 March 2020, there had only been four cases of double-lung transplantation completed successfully in patients with the novel coronavirus disease 2019 (COVID-19) worldwide. Lung transplantation is considered as the final option for critically irreversible COVID-19 patients.1 However, previous studies have demonstrated that SARS-CoV-2 may directly invade the central nervous system.2 Furthermore, the systemic inflammatory response caused by the virus may also lead to brain damage. Therefore, it is necessary to conduct a perioperative mental evaluation and urge intervention for potential mental symptoms in COVID-19 patients. Given the very little existing experience in this field, we report postoperative mental status outcomes in two elderly COVID-19 patients in China. Neither patient had a history of psychiatric disorder before virus infection. Patient 1, a 66-year-old woman with a negative history of chronic disease, was diagnosed with COVID-19 on 20 January 2020 and underwent a double-lung transplant on 1 March 2020. She had had no psychiatric symptoms between 20 January and 2 February. Delirium symptoms, characterized by restlessness and confusion, had developed on 3 February and had lasted for 7 days. She was medically sedated and arousable for 7 days before surgery. The total observation time for her was 28 days after surgery. She achieved consciousness on the 8th day after surgery. ('Consciousness' is defined as being able to open one's eyes autonomously and complete actions as instructed.) Depressed emotion appeared on the 11th day, manifesting as crying and hopelessness. Only psychological supportive treatments were applied to improve her mood, not antidepressants. Sedatives, such as zolpidem (10 mg/day) and olanzapine (5 mg/day), were used to treat insomnia, which started on the 16th day after transplant (Fig. 1a). Patient 2 was a 70-year-old man with a history of hypertension for 5 years and a 10-year history of diabetes. He was confirmed to have COVID-19 on 2 February and underwent a double-lung transplant on 8 March. He had had no psychiatric symptoms from post-viral infection until February 14, and was medically sedated and arousable thereafter until transplantation. The total observation time for him was 21 days after surgery. The time of recovering consciousness was 6 days after the surgery. He also had insomnia on the 11th day after surgery. Sleep aids zolpidem (10 mg/day) and olanzapine (5 mg/day) were used briefly. By the end of the observation period, there was no sign of insomnia, low mood, delirium, or any other severe mental symptoms (Fig. 1b). Patient 1 was virus-negative from 23 February until the end of the follow-up period, while Patient 2 was virus-negative from 18 February. Insomnia occurred in both patients after lung transplantation, and the medium onset time was 13 days after the operation. Both needed small doses of sedatives as treatment. Causes of insomnia may include the use of immunosuppressive agents,3 surgical stress, and noisy intensive care unit environments. Emotional problems occurred in one of the patients after surgery, and her mood improved only when psychological support was provided. This indicates that the main cause of poor mood might be surgical and medical stress. Given that the incidence of delirium in patients using mechanical ventilation is 50–75%,4 we closely monitored these two patients for possible postoperative delirium symptoms. Neither patient showed typical symptoms of delirium (such as disorientation, hallucinations, and agitation) or combative behavior after unsedation to consciousness. Both patients started muscle rehabilitation training 10 days after surgery. This suggests that with complete supportive care, patients with COVID-19 may avoid acute brain dysfunction after lung transplantation. Two elderly COVID-19 patients, with complete supportive care, showed no signs of severe psychiatric symptoms affecting the rehabilitation process after double-lung transplantation. However, psychological evaluation and intervention are still necessary for postoperative care. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declare no conflicts of interest.

Safety and nosocomial infection control in lung transplantation for a case of COVID-19 with end-stage ARDS

LUNG TRANSPLANTATION DURING THE OUTBREAK OF CORONAVIRUS DISEASE 2019: EARLY EXPERIENCE FROM CHINA

Lung transplantation during the outbreak of Coronavirus Disease 2019 in China

Primary Percutaneous Coronary Intervention in a COVID-19 Patient with ST-segment Elevation Myocardial Infarction after Lung Transplantation: a Case Report

Practical experiences of managing COVID-19 in lung transplantation

LUNG TRANSPLANTATION FOR AN ARDS PATIENT POST-COVID-19 INFECTION

Lung Transplantation As Therapeutic Option in Acute Respiratory Distress Syndrome for Coronavirus Disease 2019-Related Pulmonary Fibrosis.

Clinical characteristics and outcomes of lung transplantation in patients with severe COVID-19 infection: A systematic review and meta-analysis

Early Outcomes of COVID-19 Lung Transplantation Recipients in Korea: A Single-Center Study

Surgical techniques and perioperative management of lung transplantation:a report of 3 cases

Perioperative Mental Evaluation and Intervention for Lung Transplantation in Elderly Patients with COVID‐19

Treatment of Patients After Lung Transplantation With Covid Infection During Long-Term Follow-Up

Lung transplantation in patients with lung disease secondary to coronavirus disease 2019 infection

SARS-CoV-2 and lung transplantation. What do we know?

A Single-center Experience With >200 Lung Transplant Recipients With COVID-19 Infection

Lung Transplant Recipients and COVID-19: Report of Two Cases

Clinical characteristics and prognosis of SARS-CoV-2 infection in lung transplant recipients

Peri-operative Echocardiography for Lung Transplantation in a Critical Patient with COVID-19.

First Lung Transplant in Wuhan for a Critical and Elderly COVID‐19 Patient

[Clinical experience of high-flow nasal cannula oxygen therapy in severe corona virus disease 2019 (COVID-19) patients].

Lung Transplantation in the United States for COVID-19 Related Lung Disease During the Pandemic